Patents by Inventor Kailash K. Gauri

Kailash K. Gauri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5464821
    Abstract: Small peptidic compounds containing a small and branched chained amino acid residue, pharmaceutical compositions containing at least one such compound active against glaucoma and intraocular hypertension and a method for treating glaucoma and intraocular hypertension.
    Type: Grant
    Filed: September 24, 1993
    Date of Patent: November 7, 1995
    Assignee: Carlbiotech, Ltd.
    Inventors: Aasmul-Olsen Stig, Fred Widmer, Kailash K. Gauri
  • Patent number: 5411942
    Abstract: Peptide derivatives of 3-5 optionally substituted amino acids, a process for preparing the peptides, a pharmaceutical composition containing at least one peptide derivative active against glaucoma and intraocular hypertension and a method for treating glaucoma and intraocular hypertension.
    Type: Grant
    Filed: July 20, 1992
    Date of Patent: May 2, 1995
    Assignee: Carlbiotech Ltd. A/S
    Inventors: Fred Widmer, Kailash K. Gauri, Stig Aasmul-Olsen
  • Patent number: 5028436
    Abstract: In a process for separating the dissolved and undissolved constituents of milk, a microporous membrane with a pore size in the range of 0.1 to 2 .mu.m is pretreated with an aqueous solution, dispersion or emulsion of lipids or peptides and the milk is separated on the pretreated membrane.
    Type: Grant
    Filed: October 17, 1989
    Date of Patent: July 2, 1991
    Inventor: Kailash K. Gauri
  • Patent number: 4918008
    Abstract: Protein hydrolysates are described; they may be obtained by the enzymatic decomposition of whey protein, lactalbumin, .alpha.-lactalbumin, .beta.-lactoglobulin, lysozyme, lactoferrin or serum albumin. These products are suitable for pharmaceutical purposes.
    Type: Grant
    Filed: September 17, 1986
    Date of Patent: April 17, 1990
    Inventor: Kailash K. Gauri
  • Patent number: 4511557
    Abstract: Compositions for increasing oxygen supply in tissue of warm-blooded animals comprising at least one vasoactive compound selected from the group consisting of (a) calcium 2,5-dihydroxy-phenylsulfonate, (b) a 3,7-dihydro-3,7-dialkyl-1H-purine-2,6-dione of the formula ##STR1## wherein AlK and AlK' are individually alkyl of 1 to 4 carbon atoms, n is an integer from 2 to 4 and R is selected from the group consisting of ##STR2## and --CH.sub.2 --CH.sub.3, (c) a pyrazolo-[3,4-d]pyrimidine of the formula ##STR3## wherein R.sup.1 and R.sup.2 are individually selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms, alkenyl of 2 to 8 carbon atoms and alkylcarbonylalkyl of 4 to 8 carbon atoms with the proviso that R.sup.1 and R.sup.2 are not both hydrogen and A is selected from the group consisting of ##STR4## wherein R.sup.3 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms and R.sup.
    Type: Grant
    Filed: August 20, 1982
    Date of Patent: April 16, 1985
    Inventor: Kailash K. Gauri
  • Patent number: 4322404
    Abstract: Herpes virus was doubly mutated in two steps by treatment with phosphono formic acid and 5-ethyl-2'-desoxyuredine. In this way the pathogenicity of the herpes virus was so weakened that they are usable as vaccines.
    Type: Grant
    Filed: June 8, 1981
    Date of Patent: March 30, 1982
    Inventors: Kailash K. Gauri, Klaus Pressler, Klaus-Dirk Schenk
  • Patent number: 4271153
    Abstract: Novel 5-lower alkyl-2'-desoxyuridine-5'-monophosphates of the formula ##STR1## wherein R is lower alkyl of 2 to 6 carbon atoms having antiviral activity.
    Type: Grant
    Filed: April 17, 1979
    Date of Patent: June 2, 1981
    Assignee: Robugen GmbH Pharmazeutische Fabrik
    Inventor: Kailash K. Gauri